OBJECTIVE: To assess the operational feasibility of detecting human African trypanosomiasis by active and passive case finding using the card agglutination test with serial dilution of serum to guide treatment. SETTING: Trypanosomiasis control programme in the Negage focus, northern Angola, during a period of civil war. DESIGN: Observational study. PARTICIPANTS: 359 patients presenting themselves to health centres with symptoms (passive case finding) and 14,446 people actively screened in villages. MAIN OUTCOME MEASURES: Whole blood and serological tests at different dilutions using the card agglutination test, and detection of parasites by microscopy. RESULTS: Active case finding identified 251 people with a positive card agglutination test result, 10 of whom had confirmed parasites. In those presenting for investigation 34 of 51 with a positive card agglutination test result at the dilution of 1:8 or more used to guide treatment had parasites in blood, lymph node fluid, or cerebrospinal fluid, compared with 10 of 76 in those detected by active case finding: positive predictive values of 67% for passive case detection and 13% for active case detection. Only at a cut-off dilution more than 1:32 was the positive predictive value in active case detection reasonable (46%) and at this dilution 40% of microscopically proved cases were missed. CONCLUSIONS: The card agglutination test is useful for initial screening in active detection of cases with human African trypanosomiasis but, given the toxicity of the drugs, serology using the card agglutination test should be not used alone to guide treatment after active case finding. A second confirmatory test is needed.
OBJECTIVE: To assess the operational feasibility of detecting human African trypanosomiasis by active and passive case finding using the card agglutination test with serial dilution of serum to guide treatment. SETTING:Trypanosomiasis control programme in the Negage focus, northern Angola, during a period of civil war. DESIGN: Observational study. PARTICIPANTS: 359 patients presenting themselves to health centres with symptoms (passive case finding) and 14,446 people actively screened in villages. MAIN OUTCOME MEASURES: Whole blood and serological tests at different dilutions using the card agglutination test, and detection of parasites by microscopy. RESULTS: Active case finding identified 251 people with a positive card agglutination test result, 10 of whom had confirmed parasites. In those presenting for investigation 34 of 51 with a positive card agglutination test result at the dilution of 1:8 or more used to guide treatment had parasites in blood, lymph node fluid, or cerebrospinal fluid, compared with 10 of 76 in those detected by active case finding: positive predictive values of 67% for passive case detection and 13% for active case detection. Only at a cut-off dilution more than 1:32 was the positive predictive value in active case detection reasonable (46%) and at this dilution 40% of microscopically proved cases were missed. CONCLUSIONS: The card agglutination test is useful for initial screening in active detection of cases with human African trypanosomiasis but, given the toxicity of the drugs, serology using the card agglutination test should be not used alone to guide treatment after active case finding. A second confirmatory test is needed.
Authors: Pascal Lutumba; Jo Robays; Constantin Miaka; Victor Kande; Pere P Simarro; Alexandra P M Shaw; Bruno Dujardin; Marleen Boelaert Journal: Trop Med Int Health Date: 2005-04 Impact factor: 2.622
Authors: Philippe Truc; Veerle Lejon; Eddy Magnus; Vincent Jamonneau; Auguste Nangouma; Didier Verloo; Laurent Penchenier; Philippe Büscher Journal: Bull World Health Organ Date: 2002 Impact factor: 9.408
Authors: Marios C Papadopoulos; Paulo M Abel; Dan Agranoff; August Stich; Edward Tarelli; B Anthony Bell; Timothy Planche; Alison Loosemore; Samira Saadoun; Peter Wilkins; Sanjeev Krishna Journal: Lancet Date: 2004-04-24 Impact factor: 79.321
Authors: Paulo M Abel; Godi Kiala; Vanda Lôa; Markus Behrend; Jens Musolf; Hanne Fleischmann; Josénando Théophile; Sanjeev Krishna; August Stich Journal: Trop Med Int Health Date: 2004-01 Impact factor: 2.622
Authors: Paul K Drain; Emily P Hyle; Farzad Noubary; Kenneth A Freedberg; Douglas Wilson; William R Bishai; William Rodriguez; Ingrid V Bassett Journal: Lancet Infect Dis Date: 2013-12-10 Impact factor: 25.071
Authors: Jennifer J Palmer; Elizeous I Surur; Garang W Goch; Mangar A Mayen; Andreas K Lindner; Anne Pittet; Serena Kasparian; Francesco Checchi; Christopher J M Whitty Journal: PLoS Negl Trop Dis Date: 2013-01-17